Digital trials

Castor announces the appointment of Brad Hightower, a leading clinical trials executive, to its advisory board.

As we kick-off 2023 with a refreshed mindset, we take inventory of what is important and focus on our goal to continuously make sure that we are maximizing the impact of data on the global disease burden with more inclusive, patient-friendly trials.

There are ongoing debates about whether or not our industry should call all decentralized ones digital trials; however, most of us need help understanding the fundamental step to successfully operate both types of trials, which is effective data monitoring.